RYAN FRAZER: Open Payments
NPI 1720457351 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,494 in 70 payments from 12 companies in 2025. Trend: 2023 $616 · 2024 $1,074 · 2025 $1,494
Food & beverage: $1,494
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 36 | $745 |
| ViiV Healthcare Company | 17 | $383 |
| Merck Sharp & Dohme LLC | 6 | $138 |
| Indivior Inc. | 1 | $38 |
| Napo Pharmaceuticals Inc | 2 | $36 |
| Novo Nordisk Inc | 2 | $36 |
| Verity Pharmaceuticals Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $24 |
| Nalu Medical, Inc. | 1 | $19 |
| EMD Serono, Inc. | 1 | $18 |
Products named: CABENUVA, Yeztugo, PIFELTRO, Biktarvy, APRETUDE, RUKOBIA, DOVATO, SUBLOCADE.
Industry payments across AZ — which companies pay providers there.
